Country: South Africa
Language: English
Source: South African Health Products Regulatory Authority (SAHPRA)
Janssen
INDICATIONS [/za_1192.html#1] [/za_1192.html#1] [/za_1192.html#1] CONTRA-INDICATIONS [/za_1192.html#1] [/za_1192.html#1] DOSAGE [/za_1192.html#1] [/za_1192.html#1] SIDE-EFFECTS [/za_1192.html#1] [/za_1192.html#1] [/za_1192.html#1] PREGNANCY [/za_1192.html#1] [/za_1192.html#1] OVERDOSE [/za_1192.html#1] IDENTIFICATION [/za_1192.html#1] [/za_1192.html#1] PATIENT INFORMATION GYNO-DAKTARIN® 200 MG VAGINAL CAPSULE SCHEDULING STATUS: Schedule 2. PROPRIETARY NAME (and dosage form): GYNO-DAKTARIN ® 200 MG VAGINAL CAPSULE COMPOSITION Each vaginal capsule contains 200 mg of the active substance MICONAZOLE nitrate. Preservatives: Sodium ethylparaben 0,08% m/m and sodium propylparaben 0,04% m/m. PHARMACOLOGICAL CLASSIFICATION A. 18.6 Medicines acting on genito-urinary system. Vaginal preparations. PHARMACOLOGICAL ACTION PHARMACODYNAMICS Miconazole combines a potent antifungal activity against common dermatophytes and yeasts with an antibacterial activity against certain gram-positive bacilli and cocci. Miconazole inhibits the biosynthesis of ergosterol in fungi and changes the composition of other lipid components in the membrane, resulting in fungal cell necrosis. PHARMACOKINETICS Systemic absorption after intravaginal administration is limited. Unchanged miconazole could not be traced in blood plasma or urine. INDICATIONS For the relief of vaginal itching, burning and discharge associated with recurrent vaginal yeast infections. (Vaginal candidiasis). CONTRA-INDICATIONS GYNO-DAKTARIN 200 mg vaginal capsules are contra-indicated in individuals who have shown hypersensitivity to miconazole nitrate or other ingredients of the vaginal capsules. WARNINGS Use only if you have already had a vaginal yeast infection diagnosed by a medical practitioner and you have the same symptoms now, otherwise Read the complete document